BreezeBio
Develops genetic medicines enabled by precise, non-viral nanoparticle delivery across tissues
$60MSeries B
Role not disclosedActivity from announced rounds
Pitching KDB Silicon Valley? Send the deck from a free RoundOS data room and see which pages they read.